Metraipolis › archive › dc_f9aaa62dc020
Treatment patterns and outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia: a single center study from Oman — Europe PMC PMID:42528802
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42528802
- DOI
- 10.3389/fonc.2026.1866929
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T06:57:40.350Z
- SHA-256 of the archived text
1485992655a98aaee425657d8f11f8aae0ef44f39a82015fb7fdb2a13d6abaaa- Stable URL of this page
https://metraipolis.com/documento/dc_f9aaa62dc020
How to cite
Treatment patterns and outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia: a single center study from Oman — Europe PMC PMID:42528802 — Europe PMC (en), https://europepmc.org/article/MED/42528802 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f9aaa62dc020 (Metraipolis archive dc_f9aaa62dc020, sha256 1485992655a98aaee425657d8f11f8aae0ef44f39a82015fb7fdb2a13d6abaaa)
BibTeX
@misc{dcf9aaa62dc020,
title = {Treatment patterns and outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia: a single center study from Oman — Europe PMC PMID:42528802},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42528802},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f9aaa62dc020; sha256 1485992655a98aaee425657d8f11f8aae0ef44f39a82015fb7fdb2a13d6abaaa},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42528802. Agents can read the archived copy with the MCP tool read_document.